Floatz logo

Glucose-Dependent Insulinotropic Polypeptide

Cerebral Palsy (CP)

University of Copenhagenprotein_peptideN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Cerebral Palsy (CP) cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
University of California, Los Angeles
Phase 4BB
Bxcl501
Joseph Cravero
Phase 4BB
LAMOTRIGINE
Sathbhavana Brain Clinic
Phase 4BB
Tetrabenazine
Sathbhavana Brain Clinic
Phase 4BB
TRIHEXYPHENIDYL
Sathbhavana Brain Clinic
Phase 4BB

View all 23 →

Same molecule, other indications

Glucose-Dependent Insulinotropic Polypeptide is also rated in:

type 2 diabetes mellitusDormant
CCC
Indicative ·
48 / 100
View asset →
fatty liver diseaseDormant
CCC
Indicative ·
48 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →